Top

Published in:

01-08-2014 | Educational Review

Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children

Authors: Kiran Upadhyay, Richard N. Fine

Published in: Pediatric Nephrology | Issue 8/2014

Abstract

Hematopoietic stem cell transplantation (HSCT) is an accepted treatment modality for various malignant and non-malignant disorders of the lympho-hematopoietic system. Patient survival rate has increased significantly with the use of this procedure. However, with the increase in disease-free patient survival rates, complications including various organ toxicities are also common. Kidney, liver, lung, heart, and skin are among those solid organs that are commonly affected and frequently lead to organ dysfunction and eventually end-organ disease. Conservative measures may or may not be successful in managing the organ failure in these patients. Solid organ transplantation has been shown to be promising in those patients who fail conservative management. This review will summarize the causes of solid organ (kidney, liver, and lung) dysfunction and the available data on transplantation of these solid organs in post-HSCT recipients.

Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354:1813–1826PubMedCrossRef

Cohen EP (2001) Renal failure after bone-marrow transplantation. Lancet 357:6–7PubMedCrossRef

Zager RA (1994) Acute renal failure in the setting of bone marrow transplantation. Kidney Int 46:1443–1458PubMedCrossRef

Parikh CR, Coca SG (2006) Acute renal failure in hematopoietic cell transplantation. Kidney Int 69:430–435PubMedCrossRef

Paquette RL, Tran L, Landaw EM (1998) Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant 22:351–357PubMedCrossRef

Fink JC, Cooper MA, Burkhart KM, McDonald GB, Zager RA (1995) Marked enzymuria after bone marrow transplantation: a correlate of veno-occlusive disease-induced “hepatorenal syndrome”. J Am Soc Nephrol 6:1655–1660PubMed

Spitzer TR (2001) Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 27:893–898PubMedCrossRef

Cahill RA, Spitzer TR, Mazumder A (1996) Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 18:177–184PubMed

Farris AB, Taheri D, Kawai T, Fazlollahi L, Wong W, Tolkoff-Rubin N, Spitzer TR, Iafrate AJ, Preffe FI, Locascio SA, Sprangers B, Saidman S, Smith RN, Cosimi AB, Sykes M, Sachs DH, Colvin RB (2011) Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant 11:1464–1477PubMedCentralPubMedCrossRef

10.

Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, Martin PJ, Sandmaier BM, Marr KA, Appelbaum FR, Storb R, McDonald GB (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363:2091–2101PubMedCentralPubMedCrossRef

11.

Herget-Rosenthal S, Uppenkamp M, Beelen D, Kohl D, Kribben A (2000) Renal complications of high-dose chemotherapy and peripheral blood stem cell transplantation. Nephron 84:136–141PubMedCrossRef

12.

VanWhy SK, Friedman AL, Wei LJ, Hong R (1991) Renal insufficiency after bone marrow transplantation in children. Bone Marrow Transplant 7:383–388

13.

Kist-van Holthe JE, van Zwet JM, Brand R, van Weel MH, Vossen JM, van der Heijden AJ (1998) Bone marrow transplantation in children: consequences for renal function shortly after and 1-year post-BMT. Bone Marrow Transplant 22:559–564PubMedCrossRef

14.

Clajus C, Hanke N, Gottlieb J, Stadler M, Weismüller TJ, Strassburg CP, Bröcker V, Bara C, Lehner F, Drube J, Kielstein JT, Schwarz A, Gueler F, Haller H, Schiffer M (2012) Renal comorbidity after solid organ and stem cell transplantation. Am J Transplant 12:1691–1699PubMedCrossRef

15.

Ludwig P, Karim K, Felix R, Joachim M (2003) Renal function following hematological stem cell transplantation in childhood. Pediatr Nephrol 18:623–635

16.

Ileri T, Ertem M, Ozcakar ZB, Ince EU, Biyikli Z, Uysal Z, Ekim M, Yalcinkaya F (2010) Prospective evaluation of acute and chronic renal function in children following matched related donor hematopoietic stem cell transplantation. Pediatr Transplant 14:138–144PubMedCrossRef

17.

Lane PH, Mauer SM, Blazar BR, Ramsa Y, Kashtan CE (1994) Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant 13:613–617PubMed

18.

Parikh CR, McSweeney PA, Korular D, Ecder T, Merouani A, Taylor J, Slat-Vasquez V, Shpall EJ, Jones RB, Bearman SI, Schrier RW (2002) Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 62:566–573PubMedCrossRef

19.

Tarbell NJ, Guinan EC, Niemeyer C, Mauch P, Sallan SE, Weinstein HJ (1988) Late onset of renal dysfunction in survivors of bone marrow transplantation. Int J Radiat Oncol Biol Phys 15:99–104PubMedCrossRef

20.

Cohen EP, Lawton CA, Moulder JE (1995) Bone marrow transplant nephropathy: radiation nephritis revisited. Nephron 70:217–222PubMedCrossRef

21.

Weiss AS, Sandmaier BM, Storer B, Storb R, McSweeney PA, Parikh CR (2006) Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 6:89–94PubMedCrossRef

22.

Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB (2007) Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 39:223–229PubMedCrossRef

23.

Cohen EP, Piering WF, Kabler-Babbitt C, Moulder JE (1998) End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compared to other causes of ESRD. Nephron 79:408–412PubMedCrossRef

24.

Thomas SE, Hutchinson RJ, DebRoy M, Magee JC (2004) Successful renal transplantation following prior bone marrow transplantation in pediatric patients. Pediatr Transplant 8:507–512PubMedCrossRef

25.

Ellis MJ, Parikh CR, Inrig JK, Kanbay M, Patel UD (2008) Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transplant 8:2378–2390PubMedCentralPubMedCrossRef

26.

Miralbell R, Bieri S, Mermillad B, Helg C, Sancho G, Pastoors B, Keller A, Kurtz JM, Chapuis B (1996) Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol 14:579–585PubMed

27.

Leiper AD (2002) Non-endocrine late complications of bone marrow transplantation. Br J Haematol 118:3–22PubMedCrossRef

28.

Kim BK, Chung KW, Sun HS, Suh JG, Min WS, Kang CS, Sim SI, Shin WS, Kim CC (2000) Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study. Bone Marrow Transplant 26:193–197PubMedCrossRef

29.

Ozdogan O, Ratip S, al Ahdab YA, Dane F, Ahdab HA, Imeryüz N, Tözün N (2003) Causes and risk factors for liver injury following bone marrow transplantation. J Clin Gastroenterol 36:421–426PubMedCrossRef

30.

Lee SJ, Vogelsang G, Flowers ME (2003) Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9:215–233PubMedCrossRef

31.

Frisk P, Bratteby LE, Carlson K, Lonnerholm G (2002) Renal function after autologous bone marrow transplantation in children: a long-term prospective study. Bone Marrow Transplant 29:129–136PubMedCrossRef

32.

Patzer L, Ringelmann F, Kentouche K, Fuchs D, Zintl F, Brandis M, Zimmerhackl LB, Misselwitz J (2001) Renal function in long-term survivors of stem cell transplantation in childhood. A prospective trial. Bone Marrow Transplant 27:319–327PubMedCrossRef

33.

Hale GA, Bowman LC, Rochester RJ, Benaim E, Heslop HE, Krance RA, Horwitz EM, Cunningham JM, Tong X, Srivastava DK, Handgretinger R, Jones DP (2005) Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children. Biol Blood Marrow Transplant 11:912–920PubMedCrossRef

34.

Kist-Van Holthe JE, Bresters D, Ahmed-Ousenkova YM, Goedvolk CA, Abbink FC, Wolterbeek R, Bredius RG, Pauwels EK, van der Heijden AJ (2005) Long-term renal function after hematopoietic stem cell transplantation in children. Bone Marrow Transplant 36:605–610PubMedCrossRef

35.

Cohen EP, Lawton CA, Moulder JE, Becker CG, Ash RC (1993) Clinical course of late-onset bone marrow transplant nephropathy. Nephron 64:626–635PubMedCrossRef

36.

Imai H, Oyama Y, Miura AB, Endoh M, Sakai H (2000) Hematopoietic cell transplantation-related nephropathy in Japan. Am J Kidney Dis 36:474–480PubMedCrossRef

37.

Lonnerholm G, Carlson K, Bratteby LE, Backlund L, Hagberg H, Rikner G, Smedmyr B, Oberg G, Simonsson B (1991) Renal function after autologous bone marrow transplantation. Bone Marrow Transplant 8:129–134PubMed

38.

Butcher JA, Hariharan S, Adams MB, Johnson CP, Roza AM, Cohen EP (1999) Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression. Clin Transplant 13:330–335PubMedCrossRef

39.

Leblond V, Sutton L, Jacquiaud C, Item C, Sadoun R, Jaudon MC, Raymond F, Jacobs C, Deray G (1995) Evaluation of renal function in 60 long-term survivors of bone marrow transplantation. J Am Soc Nephrol 6:1661–1665PubMed

40.

Lawton CA, Cohen EP, Barberderus SW, Murray KJ, Ash RC, Casper JT, Moulder JE (1991) Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer 67:2795–2800PubMedCrossRef

41.

Schriber JR, Herzig GP (1997) Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 34:126–133PubMed

42.

Hamawi K, De Magalhaes-Silverman M, Bertolatus JA (2003) Outcomes of renal transplantation following bone marrow transplantation. Am J Transplant 3:301–305PubMedCrossRef

43.

Juncos LI, Cornejo JC, Gomes J, Baigorria S, Juncos LA (1997) Abnormal endothelium-dependent responses in early radiation nephropathy. Hypertension 30:672–676PubMedCrossRef

44.

Esiashvili N, Chiang KY, Hasselle MD, Bryant C, Riffenburgh RH, Paulino AC (2009) Renal toxicity in children undergoing total body irradiation for bone marrow transplant. Radiother Oncol 90:242–246PubMedCrossRef

45.

Antignac C, Gubler MC, Leverger G, Broyer M, Habib R (1989) Delayed renal failure with extensive mesangiolysis following bone marrow transplantation. Kidney Int 35:1336–1344PubMedCrossRef

46.

Przepiorka D, Anderlini P, Saliba R, Cleary K, Mehra R, Khouri I, Huh YO, Giralt S, Braunschweig I, van Besien K, Champlin R (2001) Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 98:1695–1701PubMedCrossRef

47.

Lin J, Markowitz GS, Nicolaides M, Hersdorffer CS, Appel GB, Dágati VD, Savage DG (2001) Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature. Am J Nephrol 21:351–356PubMedCrossRef

48.

Gomez-Garcia P, Herrera-Arroyo C, Torres-Gomez A, Gomez-Carrasco J, Aljama-Garcia P, Lopez-Rubio F, Martinez-Guibelalde F, Fornes-Torres G, Rojas-Contreras R (1988) Renal involvement in chronic graft-versus-host disease: a report of two cases. Bone Marrow Transplantation 3:357–362PubMed

49.

Hiesse C, Goldschmidt E, Santellia G, Charpentier B, Machouer D, Fries D (1988) Membranous nephropathy in a bone marrow transplant recipient. Am J Kidney Dis 11:188–191PubMedCrossRef

50.

Vischini G, Niscola P, Ferrannini M, Cupelli L, Tendas A, Scaramucci L, Giovannini M, Dentamaro T, de Fabritiis P, Palumbo R (2012) Membranous glomerulonephritis secondary to allogeneic stem cell transplant: review of the literature. G Ital Nefrol 29:394–403PubMed

51.

Brukamp K, Doyle AM, Bloom RD, Bunin N, Tomaszewski JE, Cizman B (2006) Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease? Clin J Am Soc Nephrol 1:685–694PubMedCrossRef

52.

Walker JV, Morich D, Anasetti C (1995) Minimal-change nephrotic syndrome after cyclosporine withdrawal in a marrow transplant recipient. Am J Kidney Dis 26:532–534PubMedCrossRef

53.

Perrotta S, Conte ML, La Manna A, Indolfi P, Rossi F, Locatelli F, Nobili B (2005) Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation. Haematologica 90 Suppl:ECR31

54.

Oliveira JS, Bahia D, Franco M, Balda C, Stella S, Kerbauy J (1999) Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal. Bone Marrow Transplant 23:99–101PubMedCrossRef

55.

Akar H, Keven K, Celebi H, Orhan D, Nerzigoglu G, Erbay B, Tulunay O, Ozcan M, Ertürk S (2002) Nephrotic syndrome after allogeneic peripheral blood stem cell transplantation. J Nephrol 15:79–82PubMed

56.

Kimura M, Wakabayashi T, Sata T, Mohri H, Shimada K (1990) Membranous glomerulonephritis as an outstanding feature of renal lesions in autoimmune graft-vs-host F1 mice. Jpn J Exp Med 60:235–239PubMed

57.

Seconi J, Watt V, Ritchie DS (2003) Nephrotic syndrome following allogeneic stem cell transplantation associated with increased production of TNF-alpha and interferon-gamma by donor T cells. Bone Marrow Transplant 32:447–450PubMedCrossRef

58.

Bunin N, Guzikowski V, Rand ER, Goldfarb S, Baluarte J, Meyers K, Olthoff KM (2010) Solid organ transplants following hematopoietic stem cell transplant in children. Pediatr Transplant 14:1030–1035PubMedCrossRef

59.

Sayegh MH, Fine NA, Smith JL, Rennke HG, Milford EL, Tilney NL (1991) Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 114:954–955PubMedCrossRef

60.

Dey B, Sykes M, Spitzer T (1998) Outcomes of recipients of both bone marrow and solid organ transplants: a review. Medicine (Baltimore) 77:355–369CrossRef

61.

Helg C, Chapius B, Bolle JF, Morel P, Salomon D, Roux E, Antonioli V, Jeannet M, Leski M (1994) Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation 58:1320–1421

62.

Jankowski RA, Ildstad ST (1997) Chimerism and tolerance: from freemartin cattle and neonatal mice to humans. Hum Immunol 52:155–161PubMedCrossRef

63.

Cosimi AB, Sachs DH (2004) Mixed chimerism and transplantation tolerance. Transplantation 77:943–946PubMedCrossRef

64.

Starzl TE, Murase N, Ildstad S, Ricordi C, Demetris AJ, Trucco M (1992) Cell migration, chimerism, and graft acceptance. Lancet 339:1579–1582PubMedCentralPubMedCrossRef

65.

Leventhal J, Miller J, Abecassis M, Tollerud DJ, Ildstad ST (2013) Evolving approaches of hematopoietic stem-cell based therapies to induce tolerance to organ transplants: the long road to tolerance. Clin Pharmacol Ther 93:36–45PubMedCentralPubMedCrossRef

66.

Maeng H, Lee JH, Cheong JW, Lee ST, Hahn JS, Ko YW, Min YH (2004) Chronic graft-versus-host disease of the liver presenting as an acute hepatitis following nonmyeloablative hematopoietic stem cell transplantation. Int J Hematol 79:501–504PubMedCrossRef

67.

Rosen HR, Martin P, Schiller GJ, Territo M, Lewin DN, Shackleton CR, Busuttil RW (1996) Orthotopic liver transplantation for bone-marrow transplant-associated veno-occlusive disease and graft-versus-host disease of the liver. Liver Transpl Surg 2:225–232PubMedCrossRef

68.

Smith DM, Agura E, Netto G, Collins R, Levy M, Goldstein R, Christensen L, Baker J, Altrabulsi B, Osowski L, McCormack J, Fichtel L, Dawson DB, Domiati-Saad R, Stone M, Klintmalm G (2003) Liver transplant-associated graft-versus-host disease. Transplantation 75:118–126PubMedCrossRef

69.

McDonald G, Sharma P, Matthews D, Shulman H, Thomas E (1985) The clinical course of 53 patients with venocclusive disease of the liver after marrow transplantation. Transplantation 39:603–608PubMedCrossRef

70.

Richardson P, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D, Elias AD, Antin JH, Soiffer R, Spitzer T, Avigan D, Bearman SI, Martin PL, Kurtzberg J, Vredenburgh J, Chen AR, Arai S, Vogelsang G, McDonald GB, Guinan EC (2002) Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 100:4337–4343PubMedCrossRef

71.

Barshes N, Myers G, Lee D, Karpen SJ, Lee TC, Patel AJ, Finegold M, Goss JA (2005) Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data. Liver Transpl 5:525–531CrossRef

72.

Hadzic N, Height S, Ball S, Rela M, Heaton ND, Veys P, Mieli-Vergani G (2008) Evolution in the management of acute liver failure-associated aplastic anemia in children: a single center experience. J Hepatol 48:68–73PubMedCrossRef

73.

Andreoni KA, Lin JI, Groben PA (2004) Liver transplantation 27 years after bone marrow transplantation from the same living donor. N Engl J Med 350:2624–2625PubMedCrossRef

74.

Granot E, Loewenthal R, Jakobovich E, Gazit E, Sokal E, Reding R (2012) Living related liver transplant following bone marrow transplantation from same donor: long-term survival without immunosuppression. Pediatr Transplant 16:E1–E4PubMedCrossRef

75.

Englert C, Ganschow R (2012) Liver transplantation in a child with liver failure due to chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from the same unrelated living donor. Pediatr Transplant 16:E325–E327PubMedCrossRef

76.

Urban C, Deutschmann A, Kerbl R, Lackner H, Schwinger W, Königsrainer A, Margreiter R (2002) Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 30:535–537PubMedCrossRef

77.

Afessa B, Litzow MR, Tefferi A (2001) Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 28:425–434PubMedCrossRef

78.

Soubani AO, Uberti JP (2007) Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J 29:1007–1019PubMedCrossRef

79.

Palmas A, Tefferi A, Myers JL, Scott JP, Swensen SJ, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Litzow MR (1998) Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 100:680–687PubMedCrossRef

80.

Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ (2003) Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 9:657–666PubMedCrossRef

81.

Yoshihara S, Yanik G, Cooke K, Mineishi S (2007) Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 13:749–759PubMedCrossRef

82.

Philit F, Wiesendanger T, Archimbaud E, Mornex JF, Brune J, Cordier JF (1995) Post-transplant obstructive lung disease (“bronchiolitis obliterans”): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J 8:551–558PubMed

83.

Sakaida E, Nakaseko C, Harima A, Yokota A, Cho R, Saito Y, Nishimura M (2003) Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood 102:4236–4242PubMedCrossRef

84.

Chan CK, Hyland RH, Hutcheon MA (1990) Pulmonary complications following bone marrow transplantation. Clin Chest Med 11:323–332PubMed

85.

Svendsen UG, Aggestrup S, Heilmann C, Jacobsen N, Koch C, Larsen B, Svejgaard A, Thisted B, Petterson G (1995) Transplantation of a lobe of lung from mother to child following previous transplantation with maternal bone marrow. Eur Respir J 8:334–337PubMedCrossRef

86.

Shiraishi T, Hiratsuka M, Munakata M, Higuchi T, Makihata S, Yoshinaga Y, Yamamoto S, Iwasaki A, Yasumoto M, Hamada T, Higa K, Kuraki T, Watanabe K, Morishige N, Tashiro T, Nabeshima K, Kawahara K, Okabayashi K, Yasunaga H, Shirakusa T (2007) Living-donor single-lobe lung transplantation for bronchiolitis obliterans in a 4-year-old boy. J Thorac Cardiovasc Surg 134:1092–1093PubMedCrossRef

87.

Heath JA, Kurland G, Spray TL, Kernan NA, Small TN, Brochstein JA, Gillio AP, Boklan J, O’Reilly RJ, Boulad F (2001) Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience. Transplantation 72:1986–1990PubMedCrossRef

88.

Pechet TV, de le Morena M, Mendeloff EN, Sweet SC, Shapiro SD, Huddleston CB (2003) Lung transplantation in children following treatment for malignancy. J Heart Lung Transplant 22:154–160PubMedCrossRef

89.

Yousef S, Benden C, Boyer D, Elidemir O, Frischer T, Goldfarb S, Lopez-Mitnik G, Mallory G, Visner G, Westall G, Schecter MG (2013) Lung transplantation in children following bone marrow transplantation: a multi-center experience. Pediatr Transplant 17:231–236PubMedCrossRef

90.

Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M (2007) Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 26:681–686PubMedCrossRef

91.

Gascoigne A, Corris P (1994) Lung transplants in patients with prior bone marrow transplants. Chest 105:327PubMedCrossRef

92.

Al-Githmi I, Batawil N, Shigemura N, Hsin M, Lee TW, He GW, Yim A (2006) Bronchiolitis obliterans following lung transplantation. Eur J Cardiothorac Surg 30:846–851PubMedCrossRef

93.

Okumura H, Ohtake S, Ontachi Y, Ozaki J, Shimadoi S, Waseda Y, Kondo Y, Yamazaki H, Takami A, Yasui M, Date H, Nakao S (2007) Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs? Int J Hematol 86:369–373PubMedCrossRef

94.

Kapoor S, Kurland G, Jakacki R (2000) Recurrent medulloblastoma following pediatric double-lung transplant. J Heart Lung Transplant 19:1011–1013PubMedCrossRef

95.

Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B (2005) Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106:2912–2919PubMedCentralPubMedCrossRef

96.

Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM (2003) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349:931–940PubMedCrossRef

Title: Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children
Authors: Kiran Upadhyay
Richard N. Fine
Publication date: 01-08-2014
Publisher: Springer Berlin Heidelberg
Published in: Pediatric Nephrology / Issue 8/2014
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-013-2587-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Solid organ transplantation following end-organ failure in recipients of hematopoietic stem cell transplantation in children

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2014

The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child

Pediatric solid organ transplantation and osteoporosis: a descriptive study on bone histomorphometric findings

Assessment of nutritional status in children with chronic kidney disease and on dialysis

Malcolm A. Holliday, M.D, January 12, 1924–March 26, 2014

Whole-body single-frequency bioimpedance analysis in pediatric hemodialysis patients

Rituximab in idiopathic nephrotic syndrome: does it make sense?